Financials
Financial year 2025
Gross margin
€ 3.7 million
▼ 2% vs 2024
Profit
Healthy€ 235,055
▼ 72% vs 2024
Debts
Low€ 5.9 million
▲ 15% vs 2024
EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGY from Brussel, company number BE0432894370, closed financial year 2025 with a result of € 235,055 after tax. For that financial year EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGY recorded a gross margin of € 3.7 million and equity of € 4.1 million. Compared with financial year 2024, the result moved from € 828,799 to € 235,055. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 29, 2026.
What happened at EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGY?
What happened at EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Barbara Alicia Jereczek stepped down as director. NBB
- ESTHER G.C TROOST stepped down as director. NBB
- MATTHIAS GUCKENBERGER stepped down as director. NBB
- Hurkmans Coen stepped down as director. NBB
- Luca Boldrini stepped down as director. NBB
- KERSTIN BORGMANN stepped down as director. NBB
- Catharine Clark stepped down as director. NBB
- Piet Ost stepped down as director. NBB
In short
From € 44,393 profit in 2021 to € 235,055 profit in 2025.
Best year ever: 2024, with € 828,799 profit.
On average € 135,300 of value added per employee in 2025.
A new publication or filing at EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGY? We notify you, reason included.
Follow EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGYNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Hurkmans Coen
Director
since 2025 · until 2028
Luca Boldrini
Director
since 2024 · until 2028
MATTHIAS GUCKENBERGER
Chairman of the board
since 2018 · until 2028
UULKE VAN DER HEIDE
Director
since 2023 · until 2027
since 2025 · until 2028
ANNA KIRBY
Director
since 2019 · until 2026
MARIANNE AZNAR
Director
since 2023 · until 2027
KARI TANDERUP
Director
since 2021 · until 2026
Barbara Alicia Jereczek
Director
since 2024 · until 2030
KERSTIN BORGMANN
Director
since 2022 · until 2028
Catharine Clark
Director
since 2023 · until 2028
Meattini Icro
Director
since 2023 · until 2026
ELISABETH FORDE
Director
since 2021 · until 2026
ESTHER G.C TROOST
Director
since 2021 · until 2030
Establishments
Establishment units
Physical locations of this company
Marnixlaan 17
1000 Brussel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 22 companies are registered at this address.
The Fifth Avenue Antique Shop
SIX Financial Information Belgium
€ 9.2 million revenue · 2025
ICF NEXT
€ 48.3 million revenue · 2025
AKTOR KNOWLEDGE TECHNOLOGY
€ 7.4 million revenue · 2024
CONFEDERATION OF THE EUROPEAN BICYCLE INDUSTRY
+17 more
Details
- Company number
- 0432.894.370
- VAT number
- BE 0432.894.370
- Registered office
- Marnixlaan 17, 1000 Brussel
- Names & denominations
- EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGY · ESTRO
- Enterprise type
- Rechtspersoon
- Legal form
- International non-profit association
- Legal situation
- Normale toestand
- Start date
- 4 January 1988
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Organisatie van congressen en beurzen